813 related articles for article (PubMed ID: 10090178)
1. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis.
Yamada H; Watanabe K; Saito T; Hayashi H; Niitani Y; Kikuchi T; Ito A; Fujikawa K; Lohmander LS
J Rheumatol; 1999 Mar; 26(3):654-62. PubMed ID: 10090178
[TBL] [Abstract][Full Text] [Related]
2. Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis.
Sabatini M; Lesur C; Thomas M; Chomel A; Anract P; de Nanteuil G; Pastoureau P
Arthritis Rheum; 2005 Jan; 52(1):171-80. PubMed ID: 15641085
[TBL] [Abstract][Full Text] [Related]
3. In vivo selective inhibition of mitogen-activated protein kinase kinase 1/2 in rabbit experimental osteoarthritis is associated with a reduction in the development of structural changes.
Pelletier JP; Fernandes JC; Brunet J; Moldovan F; Schrier D; Flory C; Martel-Pelletier J
Arthritis Rheum; 2003 Jun; 48(6):1582-93. PubMed ID: 12794826
[TBL] [Abstract][Full Text] [Related]
4. Esculetin suppresses proteoglycan metabolism by inhibiting the production of matrix metalloproteinases in rabbit chondrocytes.
Watanabe K; Ito A; Sato T; Saito T; Hayashi H; Niitani Y
Eur J Pharmacol; 1999 Apr; 370(3):297-305. PubMed ID: 10334506
[TBL] [Abstract][Full Text] [Related]
5. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
Baragi VM; Becher G; Bendele AM; Biesinger R; Bluhm H; Boer J; Deng H; Dodd R; Essers M; Feuerstein T; Gallagher BM; Gege C; Hochgürtel M; Hofmann M; Jaworski A; Jin L; Kiely A; Korniski B; Kroth H; Nix D; Nolte B; Piecha D; Powers TS; Richter F; Schneider M; Steeneck C; Sucholeiki I; Taveras A; Timmermann A; Van Veldhuizen J; Weik J; Wu X; Xia B
Arthritis Rheum; 2009 Jul; 60(7):2008-18. PubMed ID: 19565489
[TBL] [Abstract][Full Text] [Related]
6. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway.
Yasuda T; Poole AR
Arthritis Rheum; 2002 Jan; 46(1):138-48. PubMed ID: 11817586
[TBL] [Abstract][Full Text] [Related]
7. Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints.
Chubinskaya S; Huch K; Mikecz K; Cs-Szabo G; Hasty KA; Kuettner KE; Cole AA
Lab Invest; 1996 Jan; 74(1):232-40. PubMed ID: 8569187
[TBL] [Abstract][Full Text] [Related]
8. The role of cytokines in osteoarthritis pathophysiology.
Fernandes JC; Martel-Pelletier J; Pelletier JP
Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and mechanism of action of KHBJ-9B, a new herbal medicine, and its major compound triterpenoids in human cartilage culture and in a rabbit model of collagenase-induced osteoarthritis.
Huh JE; Baek YH; Ryu SR; Lee JD; Choi DY; Park DS
Int Immunopharmacol; 2009 Feb; 9(2):230-40. PubMed ID: 19100343
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid-induced type II collagen degradation does not correlate with matrix metalloproteinase activity in cartilage explant cultures.
Price JS; Wang-Weigand S; Bohne R; Kozaci LD; Hollander AP
Arthritis Rheum; 1999 Jan; 42(1):137-47. PubMed ID: 9920024
[TBL] [Abstract][Full Text] [Related]
11. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
[TBL] [Abstract][Full Text] [Related]
12. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
[TBL] [Abstract][Full Text] [Related]
13. [In vitro effect of alendronate on chondrocytes and articular cartilage and subchondral bone in rabbit anterior cruciate ligament transection model].
Hu H; Zhang L; Li B; Zhang Y; Liu X; Tian F; Cheng T; Wang Z
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Dec; 23(12):1474-81. PubMed ID: 20073314
[TBL] [Abstract][Full Text] [Related]
14. Effects of stromelysin activity on proteoglycan degradation of canine articular cartilage explants.
Todhunter RJ; Yeh LA; Sheldon A; Grisanzio L; Walker SL; Burton-Wurster N; Lust G
Am J Vet Res; 1995 Sep; 56(9):1241-7. PubMed ID: 7486406
[TBL] [Abstract][Full Text] [Related]
15. Activation of cartilage matrix metalloproteinases by activated protein C.
Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, reduces the progression of experimental osteoarthritis in guinea pigs.
Kobayashi T; Notoya K; Naito T; Unno S; Nakamura A; Martel-Pelletier J; Pelletier JP
Arthritis Rheum; 2005 Feb; 52(2):479-87. PubMed ID: 15692987
[TBL] [Abstract][Full Text] [Related]
17. Proteoglycan degradation after injurious compression of bovine and human articular cartilage in vitro: interaction with exogenous cytokines.
Patwari P; Cook MN; DiMicco MA; Blake SM; James IE; Kumar S; Cole AA; Lark MW; Grodzinsky AJ
Arthritis Rheum; 2003 May; 48(5):1292-301. PubMed ID: 12746902
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic effects of tenidap in canine experimental osteoarthritis: relationship with biochemical markers.
Jovanovic D; Caron JP; Martel-Pelletier J; Fernandes JC; Ricketts T; Pelletier JP
J Rheumatol; 1997 May; 24(5):916-25. PubMed ID: 9150082
[TBL] [Abstract][Full Text] [Related]
19. Water-soluble C60 fullerene prevents degeneration of articular cartilage in osteoarthritis via down-regulation of chondrocyte catabolic activity and inhibition of cartilage degeneration during disease development.
Yudoh K; Shishido K; Murayama H; Yano M; Matsubayashi K; Takada H; Nakamura H; Masuko K; Kato T; Nishioka K
Arthritis Rheum; 2007 Oct; 56(10):3307-18. PubMed ID: 17907184
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
